Advertisement
Advertisement

LONA

L

LeonaBio, Inc. Common Stock

10.04
USD
Sponsored
+0.18
+1.83%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

10.17

+0.13
+1.33%

LeonaBio, Inc. Common Stock Profile

About

LeonaBio Inc. is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. Its lead drug candidates include lasofoxifene and ATH-1105. LeonaBio Inc., formerly known as Athira Pharma Inc., is headquartered in the Seattle, Washington.

Info & Links

CEO

Mark Litton

Headquarters

18706 North Creek Parkway, Suite 104
Bothell, WA 98011, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://leonabio.com

Auditor

Ernst & Young LLP

Share holders

38

Employees

19

LeonaBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

95.57M

Enterprise Value

62.74M

Enterprise Value/EBITDA(ttm)

-0.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-340.97%

Return on Invested Capital(ttm)

-104.41%

Return on Assets(ttm)

-209.91%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-109.51M

Net Income Available to Common(ttm)

-129.41M

Diluted EPS(ttm)

-9.68

Share Statistics

Beta (5Y Monthly)

2.22

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.39M

Dividend Yield

0.00%

Float4

2.96M

% Held by Insiders

25.07%

% Held by Institutions

57.12%

Balance Sheet

Total Cash(mrq)

67.68M

Total Cash Per Share(mrq)

7.20

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.70%

Quick Ratio(mrq)

1.88%

Book Value Per Share(mrq)

6.79

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.68

Free Cash Flow(ytd)

-26.33M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement